香港股市 將收市,收市時間:1 小時 4 分鐘

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
5.28-0.01 (-0.19%)
收市:04:00PM EDT
5.49 +0.21 (+3.98%)
收市後: 07:49PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價5.29
開市5.31
買盤5.27 x 400
賣出價5.30 x 400
今日波幅5.20 - 5.49
52 週波幅4.90 - 21.04
成交量1,048,133
平均成交量1,475,200
市值443.338M
Beta 值 (5 年,每月)1.86
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-2.87
業績公佈日
遠期股息及收益率無 (無)
除息日
1 年預測目標價27.13
  • InvestorPlace

    Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024

    The ARK Innovation ETF (NYSEARCA:ARKK) has come under the spotlight recently, and there are three Cathie Wood stocks to buy with strong buy ratings for investors to consider in May this year.One of the key characteristics of the ARK Innovation ETF is its concentrated portfolio, typically holding between 35 to 55 stocks. This approach allows the fund to make significant investments in companies that ARK Invest believes have the potential to revolutionize their respective industries. However, this

  • InvestorPlace

    3 Underappreciated Stocks That Could 10x in 10 Years

    Like achieving a hole-in-one, holding a tenbagger is one of the best results any investor could wish for. A term popularized by legendary investor Peter Lynch, these stocks are innovators with the potential to grow exponentially. Indeed, 10x stocks are market disrupters and innovators. And they create products people love. Today, I’m on the hunt for three potential 10x stocks to result in a home run. To come up with the list, I screened for the following criteria: Small-mid cap stocks ($300 mill

  • Zacks

    Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

    Verve Therapeutics (VERV) delivered earnings and revenue surprises of 13.24% and 12.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?